Yasmin
Sponsors
Bayer, ViiV Healthcare, Catholic University of the Sacred Heart, Beni-Suef University, Ain Shams Maternity Hospital
Conditions
AdenomyosisContraceptionEndometriosisHIV InfectionsInfection, Human Immunodeficiency VirusPolycystic Ovary SyndromePremenstrual Syndrome
Early Phase 1
Phase 1
A Study to Evaluate the Pharmacokinetics of an Oral Contraceptive When Co-administered With GSK2248761 in Healthy Adult Female Subjects.
TerminatedNCT01195974
Start: 2010-09-14End: 2011-02-09Updated: 2019-02-20
Effects of Drospirenone-ethinylestradiol and/or NOMAC-valerate Estradiol on Cardiovascular Risk in Women With Polycystic Ovary Syndrome
NCT01603745
Start: 2012-04-30End: 2012-10-31Target: 10Updated: 2012-05-22
Phase 2
Phase 3
A Clinical Study on Yasmin® vs. Marvelon® in Chinese Women Requiring Contraception
CompletedNCT00185419
Start: 2003-11-30End: 2006-03-31Updated: 2009-01-14
Comparison Between Oral Contraceptive Pills and Calcium Supplements in Treatment of Premenstrual Syndrome
CompletedNCT02089620
Start: 2014-05-31End: 2015-06-30Updated: 2015-08-11